Cumali Yalçın

The effect of the time from diagnosis to induction therapy on prognosis in patients with acute leukemia undergoing leukapheresis for symptomatic hyperleukocytosis

B. Orhan, V. Özkocaman, F. Özkalemkaş, 2023, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience

V. Ozkocaman, F. Ozkalemkaş, B. Orhan, 2021, Turkish Journal of Internal Medicine.

Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia

C. Özakın, H. Akalın, B. Orhan, 2022, Mediterranean journal of hematology and infectious diseases.

Results of Subcutaneous and Intravenous Cladribine Treatment in Hairy Cell Leukemia Patients: A single-center Experience

V. Ozkocaman, B. Orhan, F. Özkalemkaş, 2023, Turkish Journal of Internal Medicine.

Bone Marrow Metastasis of Rhabdomyosarcoma Mimicking Acute Leukemia:A Case Report

V. Ozkocaman, B. Orhan, F. Özkalemkaş, 2021 .

The Role of White Blood Cell Count in Perianal Pathologies: A Retrospective Analysis of Hematologic Malignancies

B. Orhan, V. Özkocaman, F. Özkalemkaş, 2022, Mediterranean journal of hematology and infectious diseases.

Is split‐dose better than single‐dose? Results of Turkish Stem Cell Coordination Center (TURKOK) donors in the era of rising biosimilar G‐CSF

B. Orhan, V. Özkocaman, F. Özkalemkaş, 2022, Journal of clinical apheresis.

Potential prognostic parameters and real-world data in patients with primary central nervous system lymphoma: a new brick on the old ones

V. Ozkocaman, B. Orhan, F. Özkalemkaş, 2023, The European Research Journal.

Use of dapsone in chronic/refractory immune thrombocytopenic patients: A single center experience

V. Ozkocaman, B. Orhan, F. Özkalemkaş, 2023, Turkish Journal of Internal Medicine.

Systemic inflammatory indices for predicting prognosis of myelofibrosis

B. Orhan, V. Özkocaman, F. Özkalemkaş, 2023, Scientific reports.

Single center experience in patients with a diagnosis of nodular lymphocyte predominant Hodgkin lymphoma

V. Ozkocaman, B. Orhan, Tuba Ersal, 2021, Turkish Journal of Internal Medicine.